| Dr Jeffrey D Kellar, MD | |
|
3 E Appleby Rd Ste 401, Fayetteville, AR 72703-3163 | |
| (479) 404-2500 | |
| (479) 404-2501 |
| Full Name | Dr Jeffrey D Kellar |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 27 Years |
| Location | 3 E Appleby Rd Ste 401, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659385821 | NPI | - | NPPES |
| 621872 | Other | AR | HEALTHLINK |
| 7402386 | Other | AR | AETNA |
| 146697001 | Medicaid | AR | |
| 1077000000 | Other | AR | QUALCHOICE |
| 100075350A | Medicaid | OK | |
| 205755002 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | E3076 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Washington Regional Medical Center | Fayetteville, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington Regional Medical System | 8820995434 | 219 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
A new study shows that a drug that increases the release of growth hormone failed to slow the rate of progression of Alzheimer's disease in humans.
Researchers in the United States have identified several clinically approved compounds that could be repurposed for the treatment and prevention of coronavirus disease 2019 (COVID-19).
Coronaviruses were detected in a high proportion of bats and rodents in Viet Nam from 2013 to 2014, with an increasing proportion of positive samples found along the wildlife supply chain from traders to large markets to restaurants, according to a study published August 10 in the open-access journal PLOS ONE by Amanda Fine of the Wildlife Conservation Society and colleagues.
Kathleen Kalaf has been to hell and back in her long fight with systemic Candida. Today, thanks to a new Candida treatment that is more effective than even the most popular Candida remedies, Kalaf is finally free of the yeast overgrowth that stole eight years of her life - and she wants other Candida sufferers to know about Candida Force (http://www.candidaforce.com).
› Verified 1 days ago
| Entity Name | Ozark Surgical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013905587 PECOS PAC ID: 7911977871 Enrollment ID: O20040728000779 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
A new study shows that a drug that increases the release of growth hormone failed to slow the rate of progression of Alzheimer's disease in humans.
Researchers in the United States have identified several clinically approved compounds that could be repurposed for the treatment and prevention of coronavirus disease 2019 (COVID-19).
Coronaviruses were detected in a high proportion of bats and rodents in Viet Nam from 2013 to 2014, with an increasing proportion of positive samples found along the wildlife supply chain from traders to large markets to restaurants, according to a study published August 10 in the open-access journal PLOS ONE by Amanda Fine of the Wildlife Conservation Society and colleagues.
Kathleen Kalaf has been to hell and back in her long fight with systemic Candida. Today, thanks to a new Candida treatment that is more effective than even the most popular Candida remedies, Kalaf is finally free of the yeast overgrowth that stole eight years of her life - and she wants other Candida sufferers to know about Candida Force (http://www.candidaforce.com).
› Verified 1 days ago
| Entity Name | Washington Regional Medical System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326376419 PECOS PAC ID: 8820995434 Enrollment ID: O20100130000001 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
A new study shows that a drug that increases the release of growth hormone failed to slow the rate of progression of Alzheimer's disease in humans.
Researchers in the United States have identified several clinically approved compounds that could be repurposed for the treatment and prevention of coronavirus disease 2019 (COVID-19).
Coronaviruses were detected in a high proportion of bats and rodents in Viet Nam from 2013 to 2014, with an increasing proportion of positive samples found along the wildlife supply chain from traders to large markets to restaurants, according to a study published August 10 in the open-access journal PLOS ONE by Amanda Fine of the Wildlife Conservation Society and colleagues.
Kathleen Kalaf has been to hell and back in her long fight with systemic Candida. Today, thanks to a new Candida treatment that is more effective than even the most popular Candida remedies, Kalaf is finally free of the yeast overgrowth that stole eight years of her life - and she wants other Candida sufferers to know about Candida Force (http://www.candidaforce.com).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey D Kellar, MD 3 E Appleby Rd Ste 401, Fayetteville, AR 72703-3163 Ph: (479) 404-2500 | Dr Jeffrey D Kellar, MD 3 E Appleby Rd Ste 401, Fayetteville, AR 72703-3163 Ph: (479) 404-2500 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
A new study shows that a drug that increases the release of growth hormone failed to slow the rate of progression of Alzheimer's disease in humans.
Researchers in the United States have identified several clinically approved compounds that could be repurposed for the treatment and prevention of coronavirus disease 2019 (COVID-19).
Coronaviruses were detected in a high proportion of bats and rodents in Viet Nam from 2013 to 2014, with an increasing proportion of positive samples found along the wildlife supply chain from traders to large markets to restaurants, according to a study published August 10 in the open-access journal PLOS ONE by Amanda Fine of the Wildlife Conservation Society and colleagues.
Kathleen Kalaf has been to hell and back in her long fight with systemic Candida. Today, thanks to a new Candida treatment that is more effective than even the most popular Candida remedies, Kalaf is finally free of the yeast overgrowth that stole eight years of her life - and she wants other Candida sufferers to know about Candida Force (http://www.candidaforce.com).
› Verified 1 days ago
Dr. Ronald J Mullis, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 E Appleby Rd Ste 401, Fayetteville, AR 72703 Phone: 479-404-2500 Fax: 479-404-2501 | |
Jon M Berry, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 E Appleby Rd Ste 401, Fayetteville, AR 72703 Phone: 479-404-2500 Fax: 479-404-2501 | |
Cynthia J Amram, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 3015 E Joyce Blvd, Fayetteville, AR 72703 Phone: 479-443-4286 | |
M Gareth Eck, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 E Appleby Rd Ste 401, Fayetteville, AR 72703 Phone: 479-404-2500 Fax: 479-404-2501 | |
Caitlin Busby Sutherland, APRN Surgery Medicare: Accepting Medicare Assignments Practice Location: 3276 N Northhills Blvd, Fayetteville, AR 72703 Phone: 479-404-2110 | |
Yong S Kwon, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1695 E Rainforest Rd, Fayetteville, AR 72703 Phone: 479-445-6460 Fax: 479-445-6719 | |
Dr. Wayne A Hudec, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 E Appleby Rd Ste 401, Fayetteville, AR 72703 Phone: 479-404-2500 Fax: 479-404-2501 |